A 1-day prevalence survey was carried out in 154 French hospital wards.
Malnutrition was defined as a body mass index (BMI) <18.5 in patients <75 years old or <21 in patients ≥75 years old and/or
body weight loss >10% since disease onset. Oral food intake was measured using a visual analog scale.
RESULTS: Nutrition status was collected for 1903 patients (1109 men and 794 women, 59.3 ± 13.2 years).
Cancer was local in 25%, regional in 31%, and metastatic in 44% of patients. Performance status was 0 or 1 in 49.8%, 2 in 23.7%, 3 or 4 in 19.6% and not available in 6.5% of patients. Overall, 39% of patients were malnourished. The prevalence of
malnutrition by disease site was as follows: head and neck, 48.9%;
leukemia/
lymphoma, 34.0%; lung, 45.3%; colon/rectum, 39.3%; esophagus and/or stomach, 60.2%; pancreas, 66.7%; breast, 20.5%; ovaries/uterus, 44.8%; and prostate, 13.9%. Regional
cancer (odds ratio, 1.96; 95% confidence interval, 1.42-2.70), metastatic
cancer (2.97; 2.14-4.12), previous
chemotherapy (1.41; 1.05-1.89), and previous
radiotherapy (1.53; 1.21-1.92) were associated with
malnutrition. Only 28.4% of non-malnourished patients and 57.6% of malnourished patients received nutrition support. In all, 55% of patients stated that they were eating less than before the
cancer, while 41.4% of patients stated that they had received nutrition counseling.
CONCLUSIONS: